Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Alonso

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Medicine|May 23, 2026
Baseline immune status associates respiratory viral infection in preterm infants: A prospective cohort studyJosé Antonio Cañas, José Manuel Rodrigo-Muñoz, Laura Sánchez-García, et al.
Investigational New Drugs|May 25, 2012
Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinasesTeresa G Granda, David Cebrián, Sonia Martínez, et al.
European Journal of Endocrinology|November 4, 2021
Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es studySilvia Patricia Alonso, Sergio Valdés, Cristina Maldonado-Araque, et al.
Journal of Clinical Immunology|March 5, 2009
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patientsCinthya E Díaz-Benítez, Karla R Navarro-Fuentes, Jacqueline A Flores-Sosa, et al.
Scientific Reports|December 19, 2025
Population-based national incidence of thyroid dysfunction in SpainSilvia Patricia Alonso, Natalia Colomo, Ana Lago-Sampedro, et al.
JCO Clinical Cancer Informatics|June 14, 2024
MOSAIC: An Artificial Intelligence-Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare CancersSaverio D'Amico, Lorenzo Dall'Olio, Cesare Rollo, et al.
International Journal of Cancer|January 3, 2014
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007Laia Alemany, Silvia de Sanjosé, Sara Tous, et al.
Science Translational Medicine|January 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, et al.
The Lancet. Oncology|October 19, 2010
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose, Wim Gv Quint, Laia Alemany, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Medicine|May 23, 2026
Baseline immune status associates respiratory viral infection in preterm infants: A prospective cohort studyJosé Antonio Cañas, José Manuel Rodrigo-Muñoz, Laura Sánchez-García, et al.
Investigational New Drugs|May 25, 2012
Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinasesTeresa G Granda, David Cebrián, Sonia Martínez, et al.
European Journal of Endocrinology|November 4, 2021
Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es studySilvia Patricia Alonso, Sergio Valdés, Cristina Maldonado-Araque, et al.
Journal of Clinical Immunology|March 5, 2009
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patientsCinthya E Díaz-Benítez, Karla R Navarro-Fuentes, Jacqueline A Flores-Sosa, et al.
Scientific Reports|December 19, 2025
Population-based national incidence of thyroid dysfunction in SpainSilvia Patricia Alonso, Natalia Colomo, Ana Lago-Sampedro, et al.
JCO Clinical Cancer Informatics|June 14, 2024
MOSAIC: An Artificial Intelligence-Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare CancersSaverio D'Amico, Lorenzo Dall'Olio, Cesare Rollo, et al.
International Journal of Cancer|January 3, 2014
Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007Laia Alemany, Silvia de Sanjosé, Sara Tous, et al.
Science Translational Medicine|January 25, 2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G Olaciregui, et al.
The Lancet. Oncology|October 19, 2010
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studySilvia de Sanjose, Wim Gv Quint, Laia Alemany, et al.
Pageof 7